221 related articles for article (PubMed ID: 34976589)
1. Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis.
Hollinger KR; Sharma A; Tallon C; Lovell L; Thomas AG; Zhu X; Wiseman R; Wu Y; Kambhampati SP; Liaw K; Sharma R; Rojas C; Rais R; Kannan S; Kannan RM; Slusher BS
Nanotheranostics; 2022; 6(2):126-142. PubMed ID: 34976589
[TBL] [Abstract][Full Text] [Related]
2. Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis.
Tallon C; Sharma A; Zhang Z; Thomas AG; Ng J; Zhu X; Donoghue A; Schulte M; Joe TR; Kambhampati SP; Sharma R; Liaw K; Kannan S; Kannan RM; Slusher BS
Neurotherapeutics; 2022 Jan; 19(1):274-288. PubMed ID: 34984651
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Hollinger KR; Alt J; Riehm AM; Slusher BS; Kaplin AI
Brain Res; 2016 Mar; 1635():105-12. PubMed ID: 26826008
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.
Arteaga Cabeza O; Zhang Z; Smith Khoury E; Sheldon RA; Sharma A; Zhang F; Slusher BS; Kannan RM; Kannan S; Ferriero DM
Neurobiol Dis; 2021 Jan; 148():105201. PubMed ID: 33271328
[TBL] [Abstract][Full Text] [Related]
5. Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral Palsy.
Sah N; Zhang Z; Chime A; Fowler A; Mendez-Trendler A; Sharma A; Kannan RM; Slusher B; Kannan S
Dev Neurosci; 2023; 45(5):268-275. PubMed ID: 36990069
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy.
Zhang F; Zhang Z; Alt J; Kambhampati SP; Sharma A; Singh S; Nance E; Thomas AG; Rojas C; Rais R; Slusher BS; Kannan RM; Kannan S
J Control Release; 2023 Jun; 358():27-42. PubMed ID: 37054778
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Rahn KA; Watkins CC; Alt J; Rais R; Stathis M; Grishkan I; Crainiceau CM; Pomper MG; Rojas C; Pletnikov MV; Calabresi PA; Brandt J; Barker PB; Slusher BS; Kaplin AI
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20101-6. PubMed ID: 23169655
[TBL] [Abstract][Full Text] [Related]
8. Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.
Alnasser Y; Kambhampati SP; Nance E; Rajbhandari L; Shrestha S; Venkatesan A; Kannan RM; Kannan S
Molecules; 2018 Apr; 23(5):. PubMed ID: 29702566
[TBL] [Abstract][Full Text] [Related]
9. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
Urazaev AK; Grossfeld RM; Lieberman EM
J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
[TBL] [Abstract][Full Text] [Related]
11. A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.
Nonaka T; Yamada T; Ishimura T; Zuo D; Moffett JR; Neale JH; Yamamoto T
Mol Pain; 2017 Jan; 13():1744806917697008. PubMed ID: 28326936
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome.
Khoury ES; Sharma A; Ramireddy RR; Thomas AG; Alt J; Fowler A; Rais R; Tsukamoto T; Blue ME; Slusher B; Kannan S; Kannan RM
Theranostics; 2020; 10(13):5736-5748. PubMed ID: 32483415
[No Abstract] [Full Text] [Related]
14. Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.
Nance E; Kambhampati SP; Smith ES; Zhang Z; Zhang F; Singh S; Johnston MV; Kannan RM; Blue ME; Kannan S
J Neuroinflammation; 2017 Dec; 14(1):252. PubMed ID: 29258545
[TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications.
Neale JH; Yamamoto T
Prog Neurobiol; 2020 Jan; 184():101722. PubMed ID: 31730793
[TBL] [Abstract][Full Text] [Related]
16. Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics.
Sharma A; Liaw K; Sharma R; Zhang Z; Kannan S; Kannan RM
Theranostics; 2018; 8(20):5529-5547. PubMed ID: 30555562
[TBL] [Abstract][Full Text] [Related]
17. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
Zhang Z; Lin YA; Kim SY; Su L; Liu J; Kannan RM; Kannan S
J Neuroinflammation; 2020 Oct; 17(1):319. PubMed ID: 33100217
[TBL] [Abstract][Full Text] [Related]
18. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders.
Yang S; Datta D; Elizabeth Woo ; Duque A; Morozov YM; Arellano J; Slusher BS; Wang M; Arnsten AFT
Mol Psychiatry; 2022 Oct; 27(10):4252-4263. PubMed ID: 35732693
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
